Drug Profile
Research programme: fibroblast growth factor receptor inhibitors - Exelixis
Latest Information Update: 10 Mar 2011
Price :
$50
*
At a glance
- Originator Exelixis
- Class Small molecules
- Mechanism of Action Fibroblast growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer